Cash runway extended to early 2018; Facility to be repaid with RAPIVAB revenues. RESEARCH TRIANGLE PARK, N.C., Sept. 26, 2016-- BioCryst Pharmaceuticals, Inc. today announced that the Company has closed ...
- TheStreet.com•5 days ago
These stocks trading for less than $10 a share are within range of triggering big breakout trades. Here's how to trade them from here.
- Capital Cube•6 days ago
Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to BioCryst Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to BCRX-US. Comparing the performance and risk of BioCryst Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||4.37 x 100|
|Ask||4.76 x 1100|
|Day's Range||4.63 - 4.84|
|52wk Range||1.63 - 12.88|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-4.86|
|Avg Vol (3m)||960,442|
|Dividend & Yield||N/A (N/A)|